Wearable sensors to predict sepsis in ICU patients
Part of Infections clinical trials.
This study uses special sensor devices worn on your skin to detect early warning signs of sepsis (a dangerous blood infection). By catching sepsis earlier, doctors may be able to treat it faster and help you recover better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older and admitted to an intensive care unit (ICU)
- You must be at risk for sepsis due to conditions like existing infections, recent procedures, or invasive tubes/catheters
- You must be willing to wear two small sensor devices on your skin for the duration of your ICU stay
- Your ICU stay must be expected to last at least 6 hours
- Your skin where the sensors attach must be intact—no tattoos, open wounds, scars, or infections in that area
- You cannot already have been diagnosed with sepsis at the time you join the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a wearable skin patch placed on you during a sepsis hospital stay to help predict whether you might need to be readmitted after discharge. It may help doctors identify who is at higher risk of rehospitalization and plan follow-up care earlier.
This trial tests a wearable sweat sensor to monitor lactate levels in critically ill patients. It may help doctors track your condition more easily and comfortably.
This trial is looking for patients who have an infection and are showing early signs of getting sicker, like a high warning score. It aims to find out if doctors can identify those at risk of sepsis sooner so they can start treatment earlier.
This study tests a home monitoring system for people who come to the ER or their doctor with a serious infection that could turn into sepsis. The goal is to see if watching you at home can help catch worsening signs early and prevent hospitalization.
This trial is building a tool to predict sepsis, a life-threatening response to infection, in intensive care patients. It may help doctors act faster to prevent complications.
This study compares two blood test methods to help predict sepsis (a severe infection) and patient outcomes in the intensive care unit. It may help doctors identify high-risk patients faster and more accurately.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.